Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/28/2025

Early Screening for Gestational Diabetes in High-Risk Pregnancy

Rationale for Early Screening

  • Women with a body mass index (BMI) of 30 kg/m² or higher should be screened at their first prenatal visit to detect pre-existing undiagnosed type 2 diabetes, according to the American College of Obstetricians and Gynecologists, American Diabetes Association, and American College of Physicians 3, 4, 1
  • The American College of Obstetricians and Gynecologists recommends early screening for pregnant women with obesity due to a significantly higher risk of both pre-existing diabetes and gestational diabetes mellitus (GDM) 3, 4, 1
  • Maternal hyperglycemia directly correlates with fetal macrosomia, shoulder dystocia, and other adverse outcomes, making early screening crucial 5, 4

Specific Test to Order at 16 Weeks

  • Fasting plasma glucose ≥126 mg/dL indicates overt diabetes requiring immediate treatment, as per the American Diabetes Association 3
  • The American Diabetes Association recommends a 75g oral glucose tolerance test (OGTT) or a 50g glucose load test for screening, with specific diagnostic criteria for GDM 3, 4

Complete Screening Algorithm for This Patient

  • The American College of Obstetricians and Gynecologists recommends performing fasting plasma glucose testing at the initial visit, with a threshold of ≥92 mg/dL suggesting early GDM or impaired glucose metabolism 1, 3
  • A two-step approach for GDM screening, involving a 50g glucose load test followed by a 100g OGTT if necessary, is recommended by the American Diabetes Association 3, 4, 2
  • A one-step approach using a 75g OGTT is also acceptable, with diagnosis requiring only one abnormal value (fasting ≥92 mg/dL, 1-hr ≥180 mg/dL, or 2-hr ≥153 mg/dL) 4, 2

Critical Pitfalls to Avoid

  • Failing to rescreen at 24-28 weeks if early screening is negative can lead to missed diagnoses of GDM, which typically develops in the second or third trimester due to increasing insulin resistance 1
  • Using HbA1c for GDM screening at 24-28 weeks is not recommended, as it does not perform as well as glucose tolerance testing for GDM diagnosis 3

Postpartum Follow-up

  • The American Diabetes Association recommends screening for persistent diabetes at 4-12 weeks postpartum with a 75g OGTT using non-pregnancy diagnostic criteria 3, 4, 2
  • Lifelong screening for diabetes or prediabetes at least every 3 years is recommended, with initiation of intensive lifestyle interventions or metformin for diabetes prevention if prediabetes is identified 3, 4, 2